Search results
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance
Benzinga via Yahoo Finance· 6 days agoReported sales increased by 2.2%, which includes the anticipated decline in COVID-19 testing-related...
Abbott's device sales drive profit beat, but shares fall as forecast disappoints
Reuters· 6 days ago, opens new tab beat Wall Street estimates for quarterly profit on Wednesday on robust sales of its medical devices, but the company's stock fell 3% in morning trading, signaling disappointment ...
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
Zacks via Yahoo Finance· 6 days agoStructural Heart sales rose 13%. Heart Failure sales improved 8.4% year over year organically. The...
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ...
GuruFocus.com via Yahoo Finance· 5 days agoFull Year Organic Sales Growth Guidance: Raised to 8.5% to 10%. Medical Devices Sales Growth (Q1): 14%, with FreeStyle Libre sales at $1.5 billion, up 23% ...
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoWe believe this test has the potential to transform the standard of care for concussion testing, and...
Should You Pick Abbott Stock At $105 After An Upbeat Q1?
Forbes· 1 day agoAbbott (NYSE: ABT) recently reported its Q1 results, with revenues above and earnings exceeding our...
Abbott looks to ‘highly productive’ device pipeline for future growth
MedTech Dive via Yahoo Finance· 6 days agoCEO Robert Ford highlighted new and upcoming products throughout the earnings call, calling the...
5 stocks to watch on Wednesday: LLY, ABT and more
Seeking Alpha· 6 days agoU.S. stock index futures on Wednesday were higher, pointing to a rebound from the previous session. Wall Street's rate cut expectations took another hit...
Abbott Labs' surprise guidance bump is a major positive for its shareholders
CNBC· 6 days agoAbbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by...
Abbott stock slips despite Q1 beat (NYSE:ABT)
Seeking Alpha· 6 days agoAbbott Laboratories (ABT) stock fell even as its Q1 2024 results exceeded estimates despite a contraction in its diagnostics division. Read more here.